Usefulness of Middle Meningeal Embolization to Prevent Recurrent Spontaneous Chronic Subdural Hemorrhage.
10.7461/jcen.2018.20.1.40
- Author:
Sooji SIRH
1
;
Hye Ran PARK
;
Sukh Que PARK
Author Information
1. Department of Neurosurgery, Soonchunhyang University Seoul Hospital, Seoul, Korea. c99867@schmc.ac.kr
- Publication Type:Case Report
- Keywords:
Leukemia;
Myelomonocytic;
Subdural hematoma;
Embolization
- MeSH:
Aged;
Cerebral Hemorrhage;
Drug Therapy;
Follow-Up Studies;
Hematologic Diseases;
Hematoma, Subdural*;
Hematoma, Subdural, Chronic;
Humans;
Leukemia;
Leukemia, Myelomonocytic, Chronic;
Male;
Meningeal Arteries;
Pancytopenia;
Pathology;
Recurrence
- From:Journal of Cerebrovascular and Endovascular Neurosurgery
2018;20(1):40-46
- CountryRepublic of Korea
- Language:English
-
Abstract:
Spontaneous chronic subdural hematoma (SDH) is a rare condition that could develop in association with hematologic disease. A 66-year-old male developed a chronic SDH as an initial manifestation of chronic myelomonocytic leukemia (CMML). He experienced recurrent chronic subdural hemorrhage and newly developed intracerebral hemorrhage. Considering the scheduled long-term chemotherapy, bilateral middle meningeal artery (MMA) embolization was performed to prevent recurrence of subdural hemorrhage. Although pancytopenia occurred during the 7 months' follow-up period, residual chronic subdural hemorrhage was absorbed without recurrence. To our best knowledge, this is the first report of CMML with spontaneous chronic SDH. MMA embolization is potentially a useful and safe treatment option in the challenging clinical situations with underlying pathologies.
